BIOMAT Database Logo BIOMAT Database Logo

Bioconversion of prodrugs by conjugate-processing enzymes. 1994

S Vamvakas, and M W Anders
Institut für Toxikologie, Universität Würzburg, Germany.

UI MeSH Term Description Entries
D011355 Prodrugs A compound that, on administration, must undergo chemical conversion by metabolic processes before becoming the pharmacologically active drug for which it is a prodrug. Drug Precursor,Drug Precursors,Pro-Drug,Prodrug,Pro-Drugs,Precursor, Drug,Precursors, Drug,Pro Drug,Pro Drugs
D004798 Enzymes Biological molecules that possess catalytic activity. They may occur naturally or be synthetically created. Enzymes are usually proteins, however CATALYTIC RNA and CATALYTIC DNA molecules have also been identified. Biocatalyst,Enzyme,Biocatalysts
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001711 Biotransformation The chemical alteration of an exogenous substance by or in a biological system. The alteration may inactivate the compound or it may result in the production of an active metabolite of an inactive parent compound. The alterations may be divided into METABOLIC DETOXICATION, PHASE I and METABOLIC DETOXICATION, PHASE II.

Related Publications

S Vamvakas, and M W Anders
Enzymes involved in the bioconversion of ester-based prodrugs.
June 2006, Journal of pharmaceutical sciences,
S Vamvakas, and M W Anders
Activation of prodrugs by targeted enzymes.
January 1991, European journal of cancer (Oxford, England : 1990),
S Vamvakas, and M W Anders
Acyl-enzymes as prodrugs.
August 1989, Die Pharmazie,
S Vamvakas, and M W Anders
Carbamate ester prodrugs of dopaminergic compounds: synthesis, stability, and bioconversion.
August 1991, Journal of pharmaceutical sciences,
S Vamvakas, and M W Anders
Membrane-localized activation of glucuronide prodrugs by beta-glucuronidase enzymes.
February 2007, Cancer gene therapy,
S Vamvakas, and M W Anders
Uptake and bioconversion of stereoisomeric dipeptide prodrugs of ganciclovir by nanoparticulate carriers in corneal epithelial cells.
September 2016, Drug delivery,
S Vamvakas, and M W Anders
Design, synthesis, bioconversion, and pharmacokinetics evaluation of new ester prodrugs of olmesartan.
September 2011, European journal of medicinal chemistry,
S Vamvakas, and M W Anders
Design, synthesis, structure-function relationship, bioconversion, and pharmacokinetic evaluation of ertapenem prodrugs.
October 2014, Journal of medicinal chemistry,
S Vamvakas, and M W Anders
Novel amides and esters prodrugs of olmesartan: Synthesis, bioconversion, and pharmacokinetic evaluation.
October 2010, Bioorganic & medicinal chemistry letters,
S Vamvakas, and M W Anders
Ocular penetration and bioconversion of prostaglandin F2alpha prodrugs in rabbit cornea and conjunctiva.
October 1997, Journal of pharmaceutical sciences,
Copied contents to your clipboard!